555.png
With Technological Accumulation as the Axis and Brand Execution as the Core, THUNDEROBOT Debuts at CES 2025
January 13, 2025 08:00 ET | Thunderobot
LAS VEGAS,NV, Jan. 13, 2025 (GLOBE NEWSWIRE) -- CES 2025, the international consumer electronics show, kicked off in Las Vegas of America from January 7th to January 10th, 2025. With more than...
Picture1.png
Brian Cuban to Represent CBIH in DEA Hearings on Marijuana Reclassification
January 13, 2025 08:00 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
CBIH is proud to announce that Brian Cuban, Esq. has officially joined the Reclassification Team.
CalidiBiotherapeutics-Logo@2x.jpg
Calidi Biotherapeutics Announces Presentation of New Data of Systemic Virotherapy RTNova Platform at the AACR Annual Meeting in April 2025
January 13, 2025 08:00 ET | Calidi Biotherapeutics, Inc
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor...
sns insider pvt ltd.png
Virtual Mirror Market Size to Worth USD 76.55 Billion by 2032, at a CAGR of 24.63 | Exclusive Report by SNS Insider
January 13, 2025 08:00 ET | SNS Insider pvt ltd
Austin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Market Size & Growth Analysis: The SNS Insider report indicates that,“The Virtual Mirror Market Size was valued at USD 10.59 Billion in 2023 and is...
logo.png
ORYZON Announces First Patient Dosed in NCI-Sponsored Iadademstat in Combination With Venetoclax and Azacitidine Clinical Trial in First Line Acute Myeloid Leukemia
January 13, 2025 08:00 ET | Oryzon Genomics, S.A.
Study conducted under the CRADA agreement between NCI and Oryzon MADRID, Spain and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a...
sns insider pvt ltd.png
Multi-Function Display Market to Exceed USD 37.12 Billion by 2032, Driven by Advancements in Touchscreens, AR, and HUD Technologies | Research by SNS Insider
January 13, 2025 08:00 ET | SNS Insider pvt ltd
Austin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Market Size & Growth Analysis: The SNS Insider report indicates that,“The Multi-Function Display Market Size was valued at USD 18.7 Billion in 2023 and...
Commure-logo_full-horizontal_black (8).png
Augmedix Awarded Vizient Contract for Ambient AI Documentation Solutions
January 13, 2025 08:00 ET | Commure
SAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Augmedix, a wholly-owned subsidiary of Commure and a leader in ambient AI medical documentation, announced today that it has been awarded a contract...
Treace_color.jpg
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue
January 13, 2025 08:00 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
crk_logo.jpg
COMSTOCK RESOURCES, INC. ANNOUNCES FOURTH QUARTER 2024 EARNINGS DATE AND CONFERENCE CALL INFORMATION
January 13, 2025 08:00 ET | Comstock Resources, Inc.
FRISCO, TX, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. (NYSE:CRK) plans to release its fourth quarter 2024 results on February 18, 2025 after the market closes and host its quarterly...
DayOneBio_Logo_RGB_Square_large.jpg
Day One Reports Preliminary 2024 OJEMDA™ Net Product Revenue and Highlights 2025 Corporate Priorities
January 13, 2025 08:00 ET | Day One Biopharmaceuticals, Inc.
Preliminary 2024 OJEMDA™ (tovorafenib) net product revenue of approximately $57.2 million (unaudited) First dose cohort cleared in Phase 1a/b clinical trial of DAY301 (PTK7-targeted ADC) Ended 2024...